Abstract
Untreated cerebral AVMs carry a significant risk of long-term morbidity and mortality. Endovascular embolization has evolved into an important treatment option for most AVMs, whether it is used as an adjunct or as the primary therapy. Although sometimes a challenge to use, liquid cyanoacrylate derivatives have become the material of choice for most practitioners performing endovascular AVM embolization. In addition, advances in flow-guided microcatheter technology have enabled safer access to ever more hard-to-reach areas of the cerebral vasculature. In the current era, the treatment of cerebral AVMs seems to be best approached from a multidisciplinary standpoint at facilities where the major treatment modalities of microsurgery, stereotactic radiosurgery, and endovascular embolization are all available.
| Original language | English |
|---|---|
| Pages (from-to) | 367-380 |
| Number of pages | 14 |
| Journal | Neurosurgery Clinics of North America |
| Volume | 16 |
| Issue number | 2 SPEC. ISS. |
| DOIs | |
| State | Published - Apr 2005 |
Fingerprint
Dive into the research topics of 'Endovascular treatment of cerebral arteriovenous malformations: Indications, techniques, outcome, and complications'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver